Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

German translation, cultural adaption and validation of the unidimensional self-efficacy scale for multiple sclerosis: a study protocol.

Seebacher B, Mills RJ, Reindl M, Zamarian L, Kuisma R, Kircher S, Brenneis C, Ehling R, Deisenhammer F.

BMJ Open. 2019 Aug 20;9(8):e029565. doi: 10.1136/bmjopen-2019-029565.

2.

Bioengineering adult human heart tissue: How close are we?

Mills RJ, Hudson JE.

APL Bioeng. 2019 Mar 14;3(1):010901. doi: 10.1063/1.5070106. eCollection 2019 Mar.

3.

Use of coping strategies in MND/ALS: Association with demographic and disease-related characteristics.

Schlüter DK, Holland DP, Mills RJ, McDermott CJ, Williams TL, Young CA; TONiC study group.

Acta Neurol Scand. 2019 Aug;140(2):131-139. doi: 10.1111/ane.13113. Epub 2019 May 22.

PMID:
31058309
4.

Drug Screening in Human PSC-Cardiac Organoids Identifies Pro-proliferative Compounds Acting via the Mevalonate Pathway.

Mills RJ, Parker BL, Quaife-Ryan GA, Voges HK, Needham EJ, Bornot A, Ding M, Andersson H, Polla M, Elliott DA, Drowley L, Clausen M, Plowright AT, Barrett IP, Wang QD, James DE, Porrello ER, Hudson JE.

Cell Stem Cell. 2019 Jun 6;24(6):895-907.e6. doi: 10.1016/j.stem.2019.03.009. Epub 2019 Mar 28.

PMID:
30930147
5.

Development of a human skeletal micro muscle platform with pacing capabilities.

Mills RJ, Parker BL, Monnot P, Needham EJ, Vivien CJ, Ferguson C, Parton RG, James DE, Porrello ER, Hudson JE.

Biomaterials. 2019 Apr;198:217-227. doi: 10.1016/j.biomaterials.2018.11.030. Epub 2018 Nov 28.

PMID:
30527761
6.

Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics.

Holland DP, Schlüter DK, Young CA, Mills RJ, Rog DJ, Ford HL, Orchard K; TONiC study group.

Mult Scler Relat Disord. 2019 Jan;27:214-222. doi: 10.1016/j.msard.2018.10.016. Epub 2018 Oct 22.

PMID:
30412819
7.

Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil.

Hard ML, Wehr AY, Sadler BM, Mills RJ, von Moltke L.

Eur J Drug Metab Pharmacokinet. 2018 Aug;43(4):461-469. doi: 10.1007/s13318-018-0488-4.

8.

NKX2-5 regulates human cardiomyogenesis via a HEY2 dependent transcriptional network.

Anderson DJ, Kaplan DI, Bell KM, Koutsis K, Haynes JM, Mills RJ, Phelan DG, Qian EL, Leitoguinho AR, Arasaratnam D, Labonne T, Ng ES, Davis RP, Casini S, Passier R, Hudson JE, Porrello ER, Costa MW, Rafii A, Curl CL, Delbridge LM, Harvey RP, Oshlack A, Cheung MM, Mummery CL, Petrou S, Elefanty AG, Stanley EG, Elliott DA.

Nat Commun. 2018 Apr 10;9(1):1373. doi: 10.1038/s41467-018-03714-x.

9.

Development and validation of Spasticity Index-Amyotrophic Lateral Sclerosis.

Milinis K, Tennant A, Mills RJ, Al-Chalabi A, Burke G, Dick DJ, Ealing J, Hanemann CO, Harrower T, McDermott CJ, Majeed T, Pinto A, Talbot K, Williams T, Young CA; TONiC study group.

Acta Neurol Scand. 2018 Jul;138(1):47-54. doi: 10.1111/ane.12910. Epub 2018 Feb 21.

PMID:
29468643
10.

Preclinical models for orthopedic research and bone tissue engineering.

Schindeler A, Mills RJ, Bobyn JD, Little DG.

J Orthop Res. 2018 Mar;36(3):832-840. doi: 10.1002/jor.23824. Epub 2017 Dec 19. Review.

11.

Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest.

Mills RJ, Titmarsh DM, Koenig X, Parker BL, Ryall JG, Quaife-Ryan GA, Voges HK, Hodson MP, Ferguson C, Drowley L, Plowright AT, Needham EJ, Wang QD, Gregorevic P, Xin M, Thomas WG, Parton RG, Nielsen LK, Launikonis BS, James DE, Elliott DA, Porrello ER, Hudson JE.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):E8372-E8381. doi: 10.1073/pnas.1707316114. Epub 2017 Sep 15.

12.

Cryoinjury Model for Tissue Injury and Repair in Bioengineered Human Striated Muscle.

Mills RJ, Voges HK, Porrello ER, Hudson JE.

Methods Mol Biol. 2017;1668:209-224. doi: 10.1007/978-1-4939-7283-8_15.

PMID:
28842912
13.

Sexual functioning in multiple sclerosis: Relationships with depression, fatigue and physical function.

Young CA, Tennant A; TONiC Study Group.

Mult Scler. 2017 Aug 1;23(9):1268-1275. doi: 10.1177/1352458516675749. Epub 2016 Nov 1.

PMID:
28681643
14.

Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model.

Hard ML, Mills RJ, Sadler BM, Wehr AY, Weiden PJ, von Moltke L.

CNS Drugs. 2017 Jul;31(7):617-624. doi: 10.1007/s40263-017-0447-7.

15.

Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia.

Hard ML, Mills RJ, Sadler BM, Turncliff RZ, Citrome L.

J Clin Psychopharmacol. 2017 Jun;37(3):289-295. doi: 10.1097/JCP.0000000000000691.

16.

Development of a human cardiac organoid injury model reveals innate regenerative potential.

Voges HK, Mills RJ, Elliott DA, Parton RG, Porrello ER, Hudson JE.

Development. 2017 Mar 15;144(6):1118-1127. doi: 10.1242/dev.143966. Epub 2017 Feb 7.

17.

Urgent referral for suspected CNS cancer: which clinical features are associated with a positive predictive value of 3 % or more?

Mohammad HR, Boardman J, Howell L, Mills RJ, Emsley HC.

BMC Neurol. 2016 Aug 26;16(1):152. doi: 10.1186/s12883-016-0677-1.

18.

Induction of Human iPSC-Derived Cardiomyocyte Proliferation Revealed by Combinatorial Screening in High Density Microbioreactor Arrays.

Titmarsh DM, Glass NR, Mills RJ, Hidalgo A, Wolvetang EJ, Porrello ER, Hudson JE, Cooper-White JJ.

Sci Rep. 2016 Apr 21;6:24637. doi: 10.1038/srep24637.

19.

The Neurological Sleep Index: A suite of new sleep scales for multiple sclerosis.

Mills RJ, Tennant A, Young CA.

Mult Scler J Exp Transl Clin. 2016 Apr 7;2:2055217316642263. doi: 10.1177/2055217316642263. eCollection 2016 Jan-Dec.

20.

Copper deficiency.

Chhetri SK, Mills RJ, Shaunak S, Emsley HC.

BMJ. 2014 Jun 17;348:g3691. doi: 10.1136/bmj.g3691. No abstract available.

PMID:
24938531
21.

Is the Epworth sleepiness scale suitable for use in stroke?

Mills RJ, Koufali M, Sharma A, Tennant A, Young CA.

Top Stroke Rehabil. 2013 Nov-Dec;20(6):493-9. doi: 10.1310/tsr2006-493.

PMID:
24273296
22.

Poststroke fatigue: the patient perspective.

Young CA, Mills RJ, Gibbons C, Thornton EW.

Top Stroke Rehabil. 2013 Nov-Dec;20(6):478-84. doi: 10.1310/tsr2006-478.

PMID:
24273294
23.

Symptomatic palatal tremor following multiple listerial brainstem abscesses.

Chhetri SK, Dayanandan R, Bindman DC, Mathur S, Mills RJ.

Parkinsonism Relat Disord. 2014 Feb;20(2):253-5. doi: 10.1016/j.parkreldis.2013.11.003. Epub 2013 Nov 10. No abstract available.

PMID:
24262868
24.

Early postoperative thrombosis of an aortic bioprosthetic valve: should anticoagulation be patient specific?

Efthymiou CA, Mills RJ, O'Regan DJ.

J Card Surg. 2013 Nov;28(6):723-9. doi: 10.1111/jocs.12181. Epub 2013 Sep 2. Review.

PMID:
23992398
25.

Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS).

Mills RJ, Calabresi M, Tennant A, Young CA.

Mult Scler. 2013 Apr;19(4):502-5. doi: 10.1177/1352458512457840. Epub 2012 Aug 23.

PMID:
22917692
26.

Validation of the Neurological Fatigue Index for stroke (NFI-Stroke).

Mills RJ, Pallant JF, Koufali M, Sharma A, Day S, Tennant A, Young CA.

Health Qual Life Outcomes. 2012 May 15;10:51. doi: 10.1186/1477-7525-10-51.

27.

The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.

Young CA, Mills RJ, Woolmore J, Hawkins CP, Tennant A.

Mult Scler. 2012 Sep;18(9):1326-33. doi: 10.1177/1352458512436592. Epub 2012 Apr 5.

PMID:
22492132
28.

Tailored integrin-extracellular matrix interactions to direct human mesenchymal stem cell differentiation.

Frith JE, Mills RJ, Hudson JE, Cooper-White JJ.

Stem Cells Dev. 2012 Sep 1;21(13):2442-56. doi: 10.1089/scd.2011.0615. Epub 2012 May 31.

29.

Enteral iron supplementation in preterm and low birth weight infants.

Mills RJ, Davies MW.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD005095. doi: 10.1002/14651858.CD005095.pub2. Review.

PMID:
22419305
30.

Lateral spacing of adhesion peptides influences human mesenchymal stem cell behaviour.

Frith JE, Mills RJ, Cooper-White JJ.

J Cell Sci. 2012 Jan 15;125(Pt 2):317-27. doi: 10.1242/jcs.087916. Epub 2012 Jan 16.

31.

Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND).

Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, Talbot K, Tennant A, Young CA.

Health Qual Life Outcomes. 2011 Nov 22;9:101. doi: 10.1186/1477-7525-9-101.

32.

Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease.

Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, Talbot K, Tennant A, Young CA.

Health Qual Life Outcomes. 2011 Sep 29;9:82. doi: 10.1186/1477-7525-9-82.

33.

Effect of geometric challenges on cell migration.

Mills RJ, Frith JE, Hudson JE, Cooper-White JJ.

Tissue Eng Part C Methods. 2011 Oct;17(10):999-1010. doi: 10.1089/ten.TEC.2011.0138. Epub 2011 Jul 18.

PMID:
21631399
34.

The relationship between fatigue and other clinical features of multiple sclerosis.

Mills RJ, Young CA.

Mult Scler. 2011 May;17(5):604-12. doi: 10.1177/1352458510392262. Epub 2010 Dec 6.

PMID:
21135018
35.

A synthetic elastomer based on acrylated polypropylene glycol triol with tunable modulus for tissue engineering applications.

Hudson JE, Frith JE, Donose BC, Rondeau E, Mills RJ, Wolvetang EJ, Brooke GP, Cooper-White JJ.

Biomaterials. 2010 Nov;31(31):7937-47. doi: 10.1016/j.biomaterials.2010.07.007. Epub 2010 Aug 4.

PMID:
20688386
36.

Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis.

Mills RJ, Young CA, Pallant JF, Tennant A.

J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):1049-51. doi: 10.1136/jnnp.2008.151340. Epub 2010 Jun 14.

PMID:
20547635
37.

Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3 T.

Mills RJ, Young CA, Smith ET.

Br J Radiol. 2010 Jun;83(990):493-8. doi: 10.1259/bjr/65228893.

38.

A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors.

Hudson JE, Mills RJ, Frith JE, Brooke G, Jaramillo-Ferrada P, Wolvetang EJ, Cooper-White JJ.

Stem Cells Dev. 2011 Jan;20(1):77-87. doi: 10.1089/scd.2009.0497. Epub 2010 Nov 9.

PMID:
20446813
39.

Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS).

Mills RJ, Young CA, Pallant JF, Tennant A.

Health Qual Life Outcomes. 2010 Feb 12;8:22. doi: 10.1186/1477-7525-8-22.

40.

A cell migration device that maintains a defined surface with no cellular damage during wound edge generation.

Doran MR, Mills RJ, Parker AJ, Landman KA, Cooper-White JJ.

Lab Chip. 2009 Aug 21;9(16):2364-9. doi: 10.1039/b900791a. Epub 2009 May 14.

PMID:
19636468
41.

Rasch analysis of the Fatigue Severity Scale in multiple sclerosis.

Mills R, Young C, Nicholas R, Pallant J, Tennant A.

Mult Scler. 2009 Jan;15(1):81-7. doi: 10.1177/1352458508096215. Epub 2008 Aug 28.

PMID:
18755824
42.

A medical definition of fatigue in multiple sclerosis.

Mills RJ, Young CA.

QJM. 2008 Jan;101(1):49-60. doi: 10.1093/qjmed/hcm122. Epub 2008 Jan 14.

PMID:
18194977
43.

Treatment for ataxia in multiple sclerosis.

Mills RJ, Yap L, Young CA.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005029. Review.

PMID:
17253537
44.

3D MRI in multiple sclerosis: a study of three sequences at 3 T.

Mills RJ, Young CA, Smith ET.

Br J Radiol. 2007 May;80(953):307-20. Epub 2006 Sep 27.

PMID:
17005516
45.

Neosporosis in a pup.

Reichel MP, Thornton RN, Morgan PL, Mills RJ, Schares G.

N Z Vet J. 1998 Jun;46(3):106-10.

PMID:
16032029
46.

Tensometry of carbon fibres and elastomers at the diffractometer at BL20B of the Photon Factory.

Creagh DC, O'Neill PM, Mills RJ, Holt SA.

J Synchrotron Radiat. 1998 May 1;5(Pt 3):958-61. Epub 1998 May 1.

PMID:
15263710
47.

Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naïve healthy male volunteers under a naltrexone block.

McAleer SD, Mills RJ, Polack T, Hussain T, Rolan PE, Gibbs AD, Mullins FG, Hussein Z.

Drug Alcohol Depend. 2003 Oct 24;72(1):75-83.

PMID:
14563545
48.

Increased pre-operative platelet counts are a possible predictor for reduced sensitivity to heparin.

Vuylsteke A, Mills RJ, Crosbie AE, Burns TI, Latimer RD.

Br J Anaesth. 2000 Dec;85(6):896-8.

49.

Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention.

Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ, Hughes J.

Public Health Rep. 1998 Jun;113 Suppl 1:42-57.

50.

Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life.

Scott-Lennox JA, Mills RJ, Burt MS.

Ann Pharmacother. 1998 May;32(5):525-30.

PMID:
9606471

Supplemental Content

Loading ...
Support Center